LGBT Cancer Project

Therapeutic Areas: Oncology | Hematology

Chronic Lymphocytic Leukemia Clinical Trials

A listing of Chronic Lymphocytic Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

New York

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study evaluating thalidomide, lenalidomide and rituximab for the treatment of Chronic Lymphocytic Leukemia

Ohio

NEW

Ohio State University Comprehensive Cancer Center
Columbus Ohio

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Germany

UPDATED

Aschaffenburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Bremen

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Dortmund

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Essen Nordrhein-westfalen

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Freiburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Hamburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Heidelberg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Kaiserslautern

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Kiel

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Köln Nordrhein-westfalen

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Lemgo

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Munich

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Munster

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Reutlingen Baden-wuerttemberg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Saarbrücken Saarland

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Stuttgart

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Ulm

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Würzburg 97080

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Würzburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

Italy

NEW

Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant' Anna
Cona International

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

NEW

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST
Forli-Cesena International

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Japan

UPDATED

Aichi, Nagoya

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Eiheiji-cho

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Fukuoka

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Fukuoka-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Sendai-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

UPDATED

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma